Dr Ishwar Singh

(page 1 of 2)

£500,000 for New Antibiotic to Combat Superbugs

A new antibiotic hailed as the “last line of defence” in the battle against drug-resistant superbugs such as MRSA and VRE is taking the next step in development thanks to a UK Government grant of almost £500,000. Over the next year scientists will develop a catalogue of simplified synthetic...

Scientists pioneer ‘game-changing’ derivatives of new antibiotic

Scientists at the University of Lincoln, UK, have successfully produced two synthetic derivatives of Teixobactin – the world’s first known antibiotic capable of destroying ‘drug resistant’ bacteria. Last year, the discovery of the antibiotic Teixobactin by researchers in the USA was hailed as a ‘game-changer’ in the fight against...

Feature in leading pharmaceutical technology journal

Research from academics in the Schools of Pharmacy and Life Sciences is the focus of a feature in Innovations in Pharmaceutical Technology. ​Dr Enrico Ferrari from the School of Life Sciences, who specialises in assembling proteins, and Dr Ishwar Singh from the School of Pharmacy, who has expertise on...